KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Liabilities and Shareholders Equity (2016 - 2025)

Novartis Ag's Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $110.9 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 8.51% to $110.9 billion in Q4 2025 year-over-year; TTM through Mar 2026 was $215.3 billion, a 7.81% increase, with the full-year FY2025 number at $110.9 billion, up 8.51% from a year prior.
  • Liabilities and Shareholders Equity hit $110.9 billion in Q4 2025 for Novartis Ag, up from $104.4 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for NVS hit a ceiling of $131.8 billion in Q2 2021 and a floor of $97.5 billion in Q2 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $112.5 billion across 5 years, with a median of $111.0 billion in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 14.91% in 2023 and later rose 8.51% in 2025.
  • Tracing NVS's Liabilities and Shareholders Equity over 5 years: stood at $131.8 billion in 2021, then fell by 10.88% to $117.5 billion in 2022, then fell by 14.91% to $99.9 billion in 2023, then rose by 2.3% to $102.2 billion in 2024, then grew by 8.51% to $110.9 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for NVS at $110.9 billion in Q4 2025, $104.4 billion in Q2 2025, and $102.2 billion in Q4 2024.